IgSF11 gene appeared to be one of the most highly expressed immune checkpoints in the human glioma tumor microenvironment, compared to PDL-1, Gal-9, and CD155. IgSF11 protein was also revealed in various glioma patients’ samples. The gene discussed is LGALS9; the disease is central nervous system cancer.